Billy Mitchell, O.D.
NPI 1295717940 · Optometrist · Wynne, AR
Enrolled with Medicare as Practitioner - Optometry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1295717940
- Entity type
- Individual
- Primary specialty
- OptometristEye and Vision Services Providers
- Credential
- O.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- AR2426 (AR)
Specialties & taxonomies
Eye and Vision Services Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,464 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Complete Exam of Visual System92014 | 645 | $106 |
| Imaging of Retina92134 | 275 | $34 |
| Established Patient Problem Focused Exam of Visual System92012 | 250 | $74 |
| Photography of the Retina92250 | 104 | $31 |
| Exam of Visual Field With Extended Testing92083 | 60 | $52 |
| Imaging of Optic Nerve92133 | 53 | $28 |
| Removal of Cataract With Insertion of Prosthetic Lens |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 18 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 526 | 112 |
| Timolol Maleate | 235 | 54 |
| Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth | 100 | 78 |
| Prednisolone Acetate | 56 | 38 |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 53 | 17 |
| Bimatoprostbrand: Lumigan | 46 | — |
| Brimonidine Tartrate | 36 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$14 across 1 record (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-11-17
- Last updated
- 2011-01-13
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.